Even if the product could be reclassified to make it available for sale in pharmacies, it could not be used more frequently than every 2 3 months, so reclassification to a Pharmacy medicine would not help those who require more frequent injections. and then they also state: Our current advice to private clinics administering vitamin B12 injections which are not licensed medicinal products intravenously for non-medicinal purposes is that we do not regard these to be medicines and that they fall outside of the remit of the MHRA
The 2017 foundational studies confirmed that 5amino1mq reduces NAD consumption via NNMT inhibition, improves glucose clearance, and decreases fat accumulation.In subsequent years, the scope expanded: a 2021 study in obese mice validated its antiobesity effects, and 2024 research revealed improvements in muscle function in aged mice.To date, the compound remains in the preclinical research stage, with no largescale human clinical trials or FDA approval for human use
What are the signs of a vitamin B12 deficiency that may require injections
Cyanocobalamin injections are common for standard B12 deficiency treatment
Realistic expectation-setting: It is not a substitute for diet & exercise
Understanding non-bariatric risk factors matters because some patients have more than one reason for deficiency